We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TSSI:NASDAQTSS, Inc. Analysis

Data as of 2026-05-06 - not real-time

$17.09

Latest Price

8/10Risk

Risk Level: High

Executive Summary

TSS, Inc. (TSSI) is trading at $17.09, well below its DCF‑derived fair value of roughly $28.70, implying a material upside despite the model’s modest 5.3% estimate. The stock sits comfortably above its 20‑day (≈14.93) and 50‑day (≈12.87) simple moving averages, and the MACD line has just edged past its signal line, generating a bullish histogram, while the RSI of 64 indicates strength without being overbought. Volatility is extreme, with a 30‑day price swing near 100% and a computed beta of 3.65, underscoring high market sensitivity. Recent headlines highlight a 19.5% price surge on strong AI‑driven data‑center demand and the addition of seasoned technology veterans to the executive team, reinforcing growth expectations. Fundamentals show 21.8% revenue growth, a solid ROE of 36%, but a negative free cash flow and a debt‑to‑equity ratio of 54%, suggesting capital constraints. Compared with an industry PE average of 37.2, TSSI’s PE of 30.5 appears relatively cheap, though its price‑to‑book of 6.15 is elevated against a book value of $2.78 per share. The combination of strong top‑line momentum, undervaluation relative to peers, and heightened risk from volatility and leverage frames a nuanced picture.
Given the bullish technical setup, AI‑centric growth narrative, and valuation upside, a short‑to‑medium‑term buying stance is warranted, while long‑term exposure should be moderated by the company’s cash‑flow challenges and beta‑driven price swings.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above 20‑day and 50‑day SMAs with bullish MACD crossover
  • Strong AI/data‑center demand driving recent price rally
  • Undervalued relative to DCF fair value and industry PE

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust 21.8% revenue growth and high ROE
  • Projected upside from DCF valuation and analyst expectations
  • Executive hires adding credibility to AI‑focused strategy

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Negative free cash flow and elevated debt‑to‑equity ratio
  • High beta and near‑100% 30‑day volatility increasing price risk
  • Sustained growth potential in AI infrastructure but execution risk

Key Metrics & Analysis

Financial Health

Revenue Growth21.80%
Profit Margin6.16%
P/E Ratio30.5
ROE36.11%
ROA4.72%
Debt/Equity54.33
P/B Ratio6.2
Op. Cash Flow$34.9M
Free Cash Flow$-6252500
Industry P/E37.2

Technical Analysis

TrendNeutral
RSI64.4
Support$12.01
Resistance$17.38
MA 20$14.93
MA 50$12.87
MA 200$13.72
MACDBullish
VolumeDecreasing
Fear & Greed Index90.54

Valuation

Fair Value$28.70
Target Price$18.00
Upside/Downside5.32%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta3.65
Volatility99.72%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.